Research ArticleOriginal Research
Uric Acid as a Potential Cue to Screen for Iron Overload
Arch G. Mainous, Michele E. Knoll, Charles J. Everett, Eric M. Matheson, Mary M. Hulihan and Althea M. Grant
The Journal of the American Board of Family Medicine July 2011, 24 (4) 415-421; DOI: https://doi.org/10.3122/jabfm.2011.04.110015
Arch G. Mainous III
Michele E. Knoll
Charles J. Everett
Eric M. Matheson
Mary M. Hulihan
References
- ↵McLaren GD, McLaren CE, Adams PC, et al. Hemochromatosis and Iron Overload Screen (HEIRS) Study Research Investigators. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening. Can J Gastroenterol 2008; 22: 923–30.
- ↵Allen KJ, Gurrin LC, Constantine CC, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008; 358: 221–30.
- ↵Centers for Disease Control and Prevention. Hemochromatosis: (Iron Storage Disease), Facts, NCBDDD 6/1/2011. http://www.cdc.gov/ncbddd/hemochromatosis/facts.html.
- ↵Waalen J, Felitti VJ, Beutler E. Screening for hemochromatosis by measuring ferritin levels: a more effective approach. Blood 2008; 111: 3373–6.
- ↵US Preventive Services Task Force. Screening for hemochromatosis: recommendation statement. Ann Intern Med 2006; 145: 204–8.
- ↵
- ↵American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care 2010; 33: S11–S61.
- ↵Cooper RJ, Hoffman JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001; 134: 509–17.
- ↵Merriman TR, Dalbeth N. The genetic basis of hyperuricaemia and gout. Joint Bone Spine 2011; 78: 35–40.
- ↵Schumacher HR, Taylor W, Edwards L, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol 2009; 36: 2342–5.
- ↵Weaver AL. Epidemiology of gout. Clev Clin J Med 2008; 75(Suppl 5): S9–S12.
- ↵
- ↵Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183–90.
- ↵Ghio AJ, Ford ES, Kennedy TP, Hoidal JR. The association between serum ferritin and uric acid in humans. Free Radic Res 2005; 39: 337–42.
- ↵National Center for Health Statistics, Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. Available at: http://www.cdc.gov/nchs/nhanes.htm. Accessed 4 August 2010.
- ↵Addison G, Beamish M, Hales C, et al. An immunoradiometric assay for ferritin in the serum of normal patients and patients with iron deficiency and iron overload. J Clin Path 1972; 25: 326.
- ↵Miles L. Measurement of serum ferritin by a 2-site immunoradiometric assay. In: Abraham G, ed. Handbook of radioimmunoassay. New York: Marcel Dekker, Inc., 1977; 131–177.
- ↵Centers for Disease Control and Prevention. Hemochromatosis (iron storage disease): training & education - treatment & management. Monitoring treatment. Available at: http://www.cdc.gov/ncbddd/hemochromatosis/training/treatment/monitoring_treatment.html. Accessed 30 December 2010.
- ↵Iron Disorders Institute. Iron tests. Available at: http://www.irondisorders.org/iron-tests/. Accessed 30 December 2010.
- ↵Schlesinger N. Diagnosis of gout: clinical, laboratory, and radiologic findings. Am J Manag Care 2005; 11: S443–50.
- ↵
- ↵Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003; 138: 627–33.
- ↵Afzali A, Weiss NS, Boyko EJ, Ioannou GN. Association between serum uric acid level and chronic liver disease in the United States. Hepatology 2010; 52: 578–89.
- ↵National Center for Health Statistics, Centers for Disease Control and Prevention. NHANES 1999–2000 data documentation. Revised August 2006. Laboratory 18–biochemistry profile. Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes_99_00/lab18_doc.pdf. Accessed 18 May 2011.
- ↵Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002; 13: 2888–97.
- ↵Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol 1988; 255: F539–44.
- ↵
- ↵Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858–62.
- ↵Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41(6): 1183–90.
- ↵Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000; 148(1): 131–9.
- ↵Sudman S, Warnecke R, Johnson T, O’Rourke D, Davis AM. Cognitive aspects of reporting cancer prevention examination and texts. Vital Health Stat 6. 1994; 7: 1–171.
In this issue
Uric Acid as a Potential Cue to Screen for Iron Overload
Arch G. Mainous, Michele E. Knoll, Charles J. Everett, Eric M. Matheson, Mary M. Hulihan, Althea M. Grant
The Journal of the American Board of Family Medicine Jul 2011, 24 (4) 415-421; DOI: 10.3122/jabfm.2011.04.110015
Jump to section
Related Articles
- No related articles found.